Both in Pharmaceuticals
Aurinia Pharmaceuticals vs Septerna
Over the past year AUPH returned +19.9% and SEPN returned +146.0%; their daily moves had a correlation of 0.23.
AUPH +19.9% SEPN +146.0%Growth of $1, one year, split-adjusted
| Metric | AUPH | SEPN |
|---|---|---|
| Price | $17.11 | $47.88 |
| Market cap | $2.29B | $2.23B |
| Today | +3.32% | +9.57% |
| 1 month | +9.1% | +34.2% |
| 6 months | +5.3% | +93.8% |
| Year to date | +7.3% | +71.7% |
| 1 year | +29.9% | +138.8% |
| Revenue growth (YoY) | +13.9% | +22375.6% |
| Gross margin | 90.1% | 100.0% |
| Net margin | 37.9% | −48.7% |
| P/E (TTM) | 7.3× | — |
| Price / sales | 7.1× | 22.6× |
| Net cash | $431.7M | $372.3M |
| Dividend yield | — | — |
| Volatility (60d) | 31.0% | 49.1% |
| Short % of float | 7.3% | 12.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).